229 related articles for article (PubMed ID: 6306492)
1. Radioprotective and hemodynamic effects of WR-2721 and cystamine in rats: time course studies.
Kuna P; Volenec K; Vodicka I; Dostál M
Neoplasma; 1983; 30(3):349-57. PubMed ID: 6306492
[TBL] [Abstract][Full Text] [Related]
2. Acute hemodynamic changes in rats after intramuscular administration of a radioprotective dose of WR-2721: a comparison with cystamine.
Kuna P; Volenec K; Vodicka I; Dostál M
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1983; 26(2):225-32. PubMed ID: 6098004
[No Abstract] [Full Text] [Related]
3. Hemodynamic changes in rats after radioprotective combination of cystamine administered subcutaneously and 5-methoxytryptamine injected intramuscularly.
Kuna P
Strahlentherapie; 1976 Oct; 152(4):377-84. PubMed ID: 1068566
[TBL] [Abstract][Full Text] [Related]
4. [Radioprotective effect of gammaphos (WR-2721) and cystamine in the whole-body irradiation of mice using fission neutrons].
Kuna P; Dostál M; Neruda O; Petýrek P; Svoboda V; Resl M; Prouza Z; Hermanská Z; Spurný F; Listík E
Sb Lek; 1988 Apr; 90(4):110-6. PubMed ID: 2841753
[No Abstract] [Full Text] [Related]
5. Radioprotective effects of amifostine (WR-2721) or cystamine on radiation damage and its repair in rats whole body exposed to fission neutrons.
Kuna P; Dostál M; Neruda O; Volenec K; Vodicka I; Navrátil L; Petýrek P; Svoboda V; Simsa J; Vávrová J; Hermanská J; Prouza Z; Pitterman P; Listík E; Spurný F; Knajfl J; Podzimek F; Spelda S; Osterreicher J; Konrád F; Havránková R
Acta Medica (Hradec Kralove); 2004; 47(1):19-23. PubMed ID: 15168876
[TBL] [Abstract][Full Text] [Related]
6. Radioprotective effect of WR-2721 in rabbits: a comparison with cystamine.
Kuna P; Petýrek P; Jensovský V; Melek J
Radiobiol Radiother (Berl); 1981; 22(5):644-52. PubMed ID: 6280232
[No Abstract] [Full Text] [Related]
7. Tissue-protective effects of fullerenol C60(OH)24 and amifostine in irradiated rats.
Trajković S; Dobrić S; Jaćević V; Dragojević-Simić V; Milovanović Z; Dordević A
Colloids Surf B Biointerfaces; 2007 Jul; 58(1):39-43. PubMed ID: 17317115
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of reduction in the testicular weight by WR-2721 in relation to the body weight after whole-body gamma irradiation.
Bhartiya HC; Jaimala
Strahlenther Onkol; 1986 Jan; 162(1):68-70. PubMed ID: 3003944
[TBL] [Abstract][Full Text] [Related]
9. Chromosome protection by WR-2721 and MPG-single and combination treatments.
Thomas B; Devi PU
Strahlenther Onkol; 1987 Dec; 163(12):807-10. PubMed ID: 2827332
[TBL] [Abstract][Full Text] [Related]
10. Protection of mice against fission neutron irradiation by WR-2721 or WR-151327.
Steel LK; Jacobs AJ; Giambarresi LI; Jackson WE
Radiat Res; 1987 Mar; 109(3):469-78. PubMed ID: 3031721
[TBL] [Abstract][Full Text] [Related]
11. Radioprotective effect of WR-2721 (gammaphos) or cystamine in non-uniform lethal gamma irradiated mice.
Kuna P
Radiobiol Radiother (Berl); 1986; 27(6):761-9. PubMed ID: 3033737
[No Abstract] [Full Text] [Related]
12. Behavioral toxicity and efficacy of WR-2721 as a radioprotectant.
Bogo V; Jacobs AJ; Weiss JF
Radiat Res; 1985 Nov; 104(2 Pt 1):182-90. PubMed ID: 3001816
[TBL] [Abstract][Full Text] [Related]
13. Acute cardiovascular responses to radioprotective mixture of cystamine and 5-methoxytryptamine in rats.
Kuna P
Acta Biol Med Ger; 1975; 34(11-12):1843-9. PubMed ID: 1067710
[TBL] [Abstract][Full Text] [Related]
14. Total and local circulation changes in rabbits following cystamine administered intravenously in a radioprotective dose.
Kuna P
Strahlentherapie; 1972 Oct; 144(4):483-90. PubMed ID: 4638238
[No Abstract] [Full Text] [Related]
15. Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum(II) by WR-2721 without altering its antitumor properties.
Yuhas JM; Culo F
Cancer Treat Rep; 1980 Jan; 64(1):57-64. PubMed ID: 6247064
[TBL] [Abstract][Full Text] [Related]
16. Radiation protection of murine intestine by WR-2721, 16,16-dimethyl prostaglandin E2, and the combination of both agents.
Hanson WR
Radiat Res; 1987 Aug; 111(2):361-73. PubMed ID: 2819937
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of protective effect of aminopropylamino-ethylthiophosphate in neutron beam, gamma or X-irradiation of mice (author's transl)].
Sedlmeier H; Metzger E; Jentzsch U; Weitzenegger E
Strahlentherapie; 1981 Oct; 157(10):685-91. PubMed ID: 6272452
[TBL] [Abstract][Full Text] [Related]
18. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance.
Milas L; McBride WH; Hunter N; Ito H
Cancer Res; 1984 Jun; 44(6):2382-6. PubMed ID: 6327014
[TBL] [Abstract][Full Text] [Related]
19. WR-2721 as cytotoxic and radioprotective agent in treatment of murine lymphoma with total body irradiation.
Coia LR; Brown DQ; Hardiman J
NCI Monogr; 1988; (6):235-9. PubMed ID: 2832762
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice.
Milas L; Hunter N; Reid BO; Thames HD
Cancer Res; 1982 May; 42(5):1888-97. PubMed ID: 6279288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]